The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Irinotecan with or without capecitabine as a beyond 2nd line regime for esophago-gastric adenocarcinomas.
 
Sonal Brindley Hapuarachi
No Relationships to Disclose
 
Mohammed Dawod
No Relationships to Disclose
 
Jamie Weaver
No Relationships to Disclose
 
Fadhel Shaheen
No Relationships to Disclose
 
Adeel Khan
No Relationships to Disclose
 
Richard Hubner
Honoraria - Abbott Nutrition; Ipsen
Consulting or Advisory Role - BTG; Eisai; Shire
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; Roche
 
Tom Waddell
Honoraria - Bristol-Myers Squibb; EUSA Pharma; Ipsen; Pfizer
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Ipsen; Pfizer; Roche
Research Funding - Bristol-Myers Squibb (Inst); Ipsen (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; EUSA Pharma; Ipsen
 
Wasat Mansoor
Honoraria - Bristol-Myers Squibb; Servier
Consulting or Advisory Role - Bristol-Myers Squibb; SERVIER
Speakers' Bureau - Lilly
Travel, Accommodations, Expenses - Ipsen; SERVIER; SERVIER